Concepedia

Hotimah Masdan Salim

HM

Statistics

Publications

14

Citations

767

H-Index

12

Active since

2015

Affiliations

Tokushima University(Current)

Fukushima Medical University

The University of Tokyo

University of Oxford

Universitas Nahdlatul Ulama Indonesia

Hotimah Masdan Salim is an author at Tokushima University specializing in medicine, pharmacology, and vascular endothelial dysfunction.

ORCID

Publications per year

2015–2023

14

Publications

14

Canagliflozin reduces epicardial fat in patients with type 2 diabetes mellitus

Shusuke Yagi, Yukina Hirata, Takayuki Ise et al. · Diabetology & Metabolic Syndrome · 2017 · 183 citations · Full text

, , +17

Glycemic Control with Ipragliflozin, a Novel Selective SGLT2 Inhibitor, Ameliorated Endothelial Dysfunction in Streptozotocin-Induced Diabetic Mouse

Hotimah Masdan Salim, Daiju Fukuda, Shusuke Yagi et al. · Frontiers in Cardiovascular Medicine · 2016 · 115 citations · Full text

, , +17

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

, , +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

, , +14

Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice

Arief Rahadian, Daiju Fukuda, Hotimah Masdan Salim et al. · Journal of Atherosclerosis and Thrombosis · 2020 · 63 citations · Full text

, , +17

1–5 of 14